Bioventus logo

Bioventus

BVS | NASDAQ
Chart Builder DCF Calculator
$10.46
-$0.20 (-1.88%)
At close: Nov 16, 2026, 4:00 PM ET
$10.46
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.88%

Rating

Updated: Nov 16, 2026
69.8
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #60/1021 (Top 6%)

Key Statistics

Market Data

Market Cap $716.24M
1D Range
10.41 10.69
52W Range
6.53 15.26

Valuation (TTM)

PE 13.08
PB 2.98
EV/EBITDA 9.14

Valuation (NTM)

Forward PE 13.84
Forward PEG 0.78
Price Target $18.00
Loading financial charts...

Profile

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain tre...

Sector Healthcare
Employees 950
IPO Date Feb 11, 2021
Fiscal Year January - December

Latest News

Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

21 days ago · globenewswire.com

Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

Earnings

Latest Earnings
Nov 2, 2026
EPS
$0.17
Beat +13.64%
REV
$142.44M
Miss -4.73%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$18.00
Upside
+72.08%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.